{
    "SPADE_UN_13633": {
        "Clinical Information": [
            {
                "Medical use": "Solid tumors",
                "Company": "Lytix Biopharma",
                "Stage of Development": "Phase I",
                "Comments": "Upon transdermal injection directly into the tumor, ruxotemitide may bind to the tumor cell membranes and subsequently lyse tumor cells, thereby inducing tumor cell necrosis.",
                "Clinical Trials": [
                    "NCT01058616",
                    "NCT01986426"
                ]
            }
        ],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13633",
            "Peptide Name": "LTX-315(Oncopore, Ruxotemitide)",
            "Sequence": "KKWWKKWXK",
            "Source": "Ruxotemitide is a peptide derived from human lactoferrin, with potential lytic and immunostimulating activities.",
            "Target Organism": "No MICs found on DRAMP database",
            "Reference": [
                "Biophysical Characterization of LTX-315 Anticancer Peptide Interactions with Model Membrane Platforms: Effect of Membrane Surface Charge.(PMID:36142470)",
                "Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis.(PMID:35288467)"
            ],
            "Biological Activity": [
                "Anticancer"
            ],
            "Frequent Amino Acids": "KWX",
            "Absent Amino Acids": "ACDEFGHILMNOPQRSTUVY",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 5,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_07246",
                    "Similarity": 1.0,
                    "Sequence": "KKWKMRRNQFWIKIQREILSRPAYRKIL"
                },
                {
                    "SPADE_ID": "SPADE_N_08799",
                    "Similarity": 1.0,
                    "Sequence": "KKWKIVVIKWKK"
                },
                {
                    "SPADE_ID": "SPADE_N_08800",
                    "Similarity": 1.0,
                    "Sequence": "KKWKIVVIRWRR"
                }
            ]
        }
    }
}